Institute of Pharmaceutical Chemistry, Goethe-University, Max-von-Laue Str. 9, D-60439, Frankfurt, Germany.
Institute of Medical Microbiology and Infection Control, Hospital of Goethe-University, Paul-Ehrlich-Str. 40, D-60596, Frankfurt, Germany.
J Antimicrob Chemother. 2018 Feb 1;73(2):425-430. doi: 10.1093/jac/dkx403.
Carbapenemases such as MBLs are spreading among Gram-negative bacterial pathogens. Infections due to these MDR bacteria constitute a major global health challenge. Therapeutic strategies against carbapenemase-producing bacteria include β-lactamase inhibitor combinations. [S,S]-ethylenediamine-N,N'-disuccinic acid (EDDS) is a chelator and potential inhibitor of MBLs. We investigated the activity of EDDS in combination with imipenem against MBL-producing bacteria in vitro as well as in vivo.
The inhibitory activity of EDDS was analysed by means of a fluorescence-based assay using purified recombinant MBLs, i.e. NDM-1, VIM-1, SIM-1 and IMP-1. The in vitro activity of imipenem ± EDDS against mutants as well as clinical isolates expressing MBLs was evaluated by broth microdilution assay. The in vivo activity of imipenem ± EDDS was analysed in a Galleria mellonella infection model.
EDDS revealed potent MBL inhibitory activity against purified NDM-1, weaker activity against VIM-1 and SIM-1, and marginal activity against IMP-1. EDDS did not exhibit any intrinsic antibacterial activity, but enabled a concentration-dependent potentiation of imipenem against mutants as well as clinical isolates expressing various MBLs. The in vivo model showed a significantly better survival rate for imipenem + EDDS-treated G. mellonella larvae infected with NDM-1-producing Klebsiella pneumoniae compared with monotherapy with imipenem.
The bacterial natural zincophore EDDS is a potent MBL inhibitor and in combination with imipenem overcomes MBL-mediated carbapenem resistance in vitro and in vivo.
碳青霉烯酶如 MBL 正在革兰氏阴性细菌病原体中传播。这些 MDR 细菌引起的感染构成了一个主要的全球健康挑战。针对产碳青霉烯酶细菌的治疗策略包括β-内酰胺酶抑制剂组合。[S,S]-乙二胺-N,N'-二琥珀酸(EDDS)是一种螯合剂和 MBL 的潜在抑制剂。我们研究了 EDDS 与亚胺培南联合对产 MBL 细菌的体外和体内活性。
使用纯化的重组 MBL,即 NDM-1、VIM-1、SIM-1 和 IMP-1,通过基于荧光的测定分析 EDDS 的抑制活性。通过肉汤微量稀释法评估亚胺培南±EDDS 对表达 MBL 的突变体和临床分离株的体外活性。在 Galleria mellonella 感染模型中分析了亚胺培南±EDDS 的体内活性。
EDDS 对纯化的 NDM-1 具有很强的 MBL 抑制活性,对 VIM-1 和 SIM-1 的活性较弱,对 IMP-1 的活性较弱。EDDS 本身没有任何抗菌活性,但能够使亚胺培南对表达各种 MBL 的突变体和临床分离株产生浓度依赖性的增效作用。体内模型显示,与亚胺培南单药治疗相比,亚胺培南+EDDS 治疗的携带 NDM-1 产肺炎克雷伯菌的 G. mellonella 幼虫的存活率显著提高。
细菌天然锌载体 EDDS 是一种有效的 MBL 抑制剂,与亚胺培南联合使用可在体外和体内克服 MBL 介导的碳青霉烯类耐药性。